Seattle startup Proprio raised a $43 million Series B round following FDA clearance for its surgical navigation platform that allows clinicians to see key structures on a screen in three dimensions in real time.
- The company’s system, called Paradigm, helps clinicians place incisions and guide placement of hardware, such as devices that can help straighten a spine.
- Paradigm captures high-definition images of the operating field from above and fuses them with images of pre-operative three-dimensional scans. The system relies on advances in light field imaging, computer vision, machine learning, robotics and augmented reality.
- Paradigm has been used in surgeries with select hospital systems to collect data during development. The company received 510(k) clearance in April, demonstrating that its technology is safe and effective. Proprio is now preparing Paradigm for human use in live cases this summer.
- Founded in 2016 and spun out of the University of Washington, Proprio employs 40 people and has raised $73 million to date. Investors in the latest round include Bird B. AG; Wheelhouse Capital; DCVC; BOLD Capital Partners; Jaime Montealegre; and Naveen Jain.
Previously: Seattle startup aims to change surgery using AI, computer vision and augmented reality
